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CORRESPONDENCE
Acinetobacter baumannii respiratory isolates
in ventilated patients are associated with
prolonged hospital stay
10.1111/j.1469-0691.2006.01411.x
We read with interest the excellent review in CMI
[1] concerning the clinical impact and pathogen-
icity of Acinetobacter, and wish to contribute our
own observations from Malaysia. In a retrospec-
tive review of 404 cases of mechanically-ventila-
ted patients in our urban-based, 800-bed,
university teaching hospital in Malaysia between
2003 and 2004, 102 (25.2%) patients yielded
negative cultures, and Acinetobacter baumannii
ranked highest among all positive respiratory
isolates, accounting for 141 (46.7%) of all patients
yielding positive cultures. Only 16.7% of A. bau-
mannii isolates showed susceptibility to all
major potent antibiotic classes (extended-spec-
trum b-lactams, fourth-generation cephalospo-
rins, carbapenems and aminoglycosides), while
68.1% of isolates showed multiresistance.
To investigate the clinical relevance of respirat-
ory cultures positive for A. baumannii in ventilated
patients, the hospital mortality and length of
hospital stay of patients with A. baumannii were
compared with those of patients with negative
cultures. In order to allow meaningful compar-
ison, only patients with single cultures of A. bau-
mannii (n = 72; 46.9% male; age (SD) 46 (19.7)
years) and those for whom cultures were consis-
tently negative (n = 91; male 53.1%; age (SD) 49
(19.2) years) were studied, and only isolates from
unprotected tracheal aspirates (98.8%) and
bronchoscopic specimens (1.2%) were studied.
The results showed that the crude hospital mor-
tality rates for the A. baumannii-positive and the
A. baumannii-negative groups did not differ signi-
ficantly (40.3% and 36.3%, respectively; p 0.6, v2
test), but that the median (interquartile range 25–
75) length of hospital stay was significantly dif-
ferent (20 (10–35) days and 10 (5–21) days,
respectively; p < 0.001, Mann–Whitney test)
(Fig. 1). Analysis based on in-vitro antibiotic
resistance (extended-spectrum b-lactams, 59.7%;
fourth-generation cephalosporin, 54.2%; carbap-
enems, 47.2%; aminoglycosides, 48.6%) gave sim-
ilar findings with respect to mortality (p 0.33–0.50)
and length of hospital stay (p 0.001–0.011).
While the absence of statistical differences in
crude hospital mortality rates may be a result of
the study being underpowered, the significant
difference in the length of hospital stay between
those patients with A. baumannii and those who
yielded negative cultures is striking, and is likely
to represent a genuine association. We intention-
ally compared patients who yielded A. baumannii
isolates and those with negative cultures because
this comparison clearly delineates the common
clinical scenario that requires judgement on whe-
ther to initiate an antibiotic regimen or change an
existing one [2]. Previously, it had been our
general departmental policy to refrain from treat-
ing patients with positive cultures of A. baumannii
alone, although such data were not collected for
the purpose of this study. The above findings
constitute further evidence for increasing respir-
atory infection ⁄ colonisation with A. baumannii
of ventilated patients [1], and the decision on
whether to treat positive respiratory isolates
of A. baumannii should be taken with care [3].
This concern is appropriate in the light of esca-
lating antibiotic resistance worldwide and the
strong advocacy for judicious use of potent,
extended-spectrum, reserved antibiotics.
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Fig. 1. Crude hospital mortality rate and length of hospital
stay for mechanically-ventilated patients with Acinetobacter
baumannii (Ac B) respiratory isolates, compared with
patients with negative cultures. Horizontal bars represent
median values.
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Anaerobic bacteraemia in cancer patients
10.1111/j.1469-0691.2006.01412.x
The recent article in CMI by Zahar et al. [1]
reported 45 cases of anaerobic bacteraemia in
cancer patients during a 6-year period. The
authors made the important point that, although
these infections occur infrequently, they can be
serious, and even fatal. The use of some antimi-
crobial agents, such as ceftazidime, as initial
monotherapy for fever does not provide coverage
for anaerobic bacteria. Delayed administration of
appropriate therapy, or inappropriate therapy,
results in substantially higher mortality rates.
A review of 451 episodes of anaerobic bacter-
aemia was conducted at the University of Texas
M. D. Anderson Cancer Center, covering the
period from 1972 to 1983 [2,3]. Apparently, many
physicians are not aware of this large review. The
large number of cases made it possible to analyse
clostridial infections separately from infections
caused by non-sporulating anaerobes, which is
important because some Clostridium spp., most
notably Clostridium perfringens and Clostridium
septicum, produce potent toxins that can cause
characteristic presentations.
The majority (70%) of the 451 infections were
caused by non-sporulating anaerobes, predomin-
antly Bacteroides spp., and especially Bacteroides
fragilis; C. perfringens and C. septicum were the
most common causes of clostridial infection. In
both groups, the most frequent underlying malig-
nancies were acute leukaemia, and genitourinary
and gastrointestinal malignancies. Polymicrobial
infection occurred in 27% of the cases. Among
patients with infections caused by non-sporulat-
ing organisms, 48% had abdominal abscesses,
28% had soft tissue infection and necrosis, and
28% presented with septic shock. Among patients
with clostridial infections, 38% had abdominal or
rectal abscesses, necrotic tumours or peritonitis,
44% had soft tissue infections (11% with necro-
sis), and 38% presented with septic shock. Occa-
sional patients with clostridial infections had gas
gangrene, disseminated crepitant skin lesions, or
acute haemolysis. C. septicum infections were
associated with typhlitis in neutropenic patients
with acute leukaemia.
The overall cure rates were 70% for patients
with non-sporulating anaerobic infections, and
58% for patients with clostridial infections. Cure
rates were lower in patients with septic shock,
pneumonia, polymicrobial infection, and persist-
ent severe neutropenia.
It is apparent from both the older and current
studies that, while they are not frequent, anaer-
obic infections are often serious and can be fatal if
not treated early with appropriate antimicrobial
agents. Hence, those patients with abdominal
symptoms, peri-rectal abscesses or necrotic skin
lesions, and especially those patients with under-
lying acute leukaemia, or genitourinary or
gastrointestinal malignancies, should receive
anaerobic coverage as part of their initial empir-
ical therapy.
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